Related Experiment Videos
Interpretation of hypercalcemia in a patient with end-stage renal disease
1Nephrology/Hypertension Section, Department of Veterans Affairs Lakeside Medical Center, Chicago, Ill.
Insights
Patients with kidney failure and multiple myeloma need accurate ionized calcium measurements. Standard calculations can overestimate levels, potentially leading to incorrect treatment. Direct measurement is crucial for safe and effective care.
Area of Science:
- Nephrology
- Oncology
- Clinical Chemistry
Background:
- Patients with end-stage renal disease (ESRD) and multiple myeloma (MM) face complex calcium (Ca) homeostasis challenges.
- Routine laboratory tests often report only total calcium, necessitating calculations for ionized calcium (iCa) to guide clinical decisions.
- Accurate iCa assessment is vital for managing these complex patient populations.
Observation:
- A case study involved a patient with multiple myeloma undergoing hemodialysis.
- The patient exhibited a significantly elevated total calcium level.
- Concurrently, the ionized calcium level showed only a minimal increase.
Findings:
- Commonly employed algorithms for estimating iCa from total calcium overestimated the actual iCa in this patient.
- These overestimations could potentially lead to inappropriate therapeutic interventions.
- The discrepancy highlights limitations in calculated iCa values in specific clinical scenarios.
Implications:
- Direct measurement of ionized calcium is essential when treatment decisions critically depend on its level.
- Relying solely on calculated iCa in ESRD and MM patients may pose significant clinical risks.
- This underscores the need for careful consideration of measurement methods in complex metabolic conditions.
Abstract:
Patients with both end-stage renal disease and multiple myeloma are prone to changes in ionized calcium homeostasis that may have grave consequences. However, only total calcium level is reported in most routine laboratory testing, with various algorithms used to derive the physiologically important ionized or free calcium level to guide treatment. We studied a patient with multiple myeloma undergoing long-term hemodialysis who presented with a markedly elevated total calcium level but with only minimal elevation in the ionized calcium level. All of the commonly used algorithms would have overestimated the ionized calcium level, and some of these might have led to inappropriate treatment. When therapy depends critically on the ionized calcium level, direct measurement is essential.